store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 256.00 | |
5 mg | In stock | $ 628.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,980.00 | |
50 mg | In stock | $ 3,160.00 | |
100 mg | In stock | $ 5,160.00 |
Description | Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults. |
In vitro | Orforglipron potently stimulates GLP-1R-induced cAMP accumulation with partial agonist activity and no detectable recruitment of GLP-1R-mediated β-arrestin was observed[2]. |
Synonyms | LY3502970, GLP-1 receptor agonist 1 |
Molecular Weight | 882.96 |
Formula | C48H48F2N10O5 |
CAS No. | 2212020-52-3 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 44.15 mg/mL (50 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Orforglipron 2212020-52-3 GPCR/G Protein Glucagon Receptor LY-3502970 LY3502970 LY 3502970 GLP-1 receptor agonist 1 inhibitor inhibit